fostemsavir Report issue

Small molecule Approved FDA Fast Track FDA Breakthrough Therapy FDA Priority Review FDA

Active Ingredient History

  • Now
Fostemsavir, sold under the brand name Rukobia, is an antiretroviral medication for adults living with HIV/AIDS who have tried multiple HIV medications and whose HIV infection cannot be successfully treated with other therapies because of resistance, intolerance or safety considerations.   Wikipedia

  • SMILES: COc1cnc(c2c1c(cn2COP(=O)(O)O)C(=O)C(=O)N3CCN(CC3)C(=O)c4ccccc4)n5cnc(C)n5
  • Mol. Mass: 583.5
  • ALogP: 1.17
  • ChEMBL Molecule:
More Chemistry

Drug Pricing (per unit)

United States

$93.6273 - $125.5778
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

bms-663068 | cpi-0610 | fostemsavir


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue